Oramed Pharmaceuticals Inc. has signed a non-binding term sheet with Hefei Tianhui Biotech Co., Ltd. (HTIT) to establish a joint venture based on Oramed’s oral drug delivery technology. The proposed joint venture would focus on the development and worldwide commercialization of innovative products based on Oramed’s oral insulin and protein oral delivery (POD) pipeline and HTIT’s manufacturing capabilities and technologies. The joint venture would be responsible for developin...